0 NASDAQ Companies - September 19, 2019PDS Biotechnology Reports Clinical Data for Its Novel Immunotherapy PDS0101 in Follow up to Phase 1 Human TrialRead More
0 NASDAQ Companies - September 19, 2019Kratos Receives $35 Million Sole-Source USAF IDIQ Contract for Subscale Aerial Target SparesRead More
0 NASDAQ Companies - September 19, 2019Avalon GloboCare Announces Initiation of First-in-Human Clinical Trial of its CAR-T Candidate, AVA-001, for Treatment of B-Cell MalignanciesRead More
0 NASDAQ Companies - September 19, 2019Soleno Therapeutics to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease CompaniesRead More
0 NASDAQ Companies - September 19, 2019Momenta Pharmaceuticals Appoints Dr. Donna Grogan to Board of DirectorsRead More
0 NASDAQ Companies - September 19, 2019Mercer International Inc. Announces Proposed Add-On Offering of $200 Million of Senior Notes Due 2025 and Redemption of 7.750% Senior Notes Due 2022Read More
0 NASDAQ Companies - September 19, 2019Strongbridge Biopharma plc Announces RECORLEV™ (levoketoconazole) Phase 3 SONICS Data Published in The Lancet Diabetes & EndocrinologyRead More
0 NASDAQ Companies - September 19, 2019Pacira BioSciences Appoints Chris Christie to Board of DirectorsRead More
0 NASDAQ Companies - September 19, 2019The Joint Corp. to Present at the 5th Annual B. Riley FBR Consumer & Media ConferenceRead More
0 NASDAQ Companies - September 19, 2019Clearside Biomedical Featured at Multiple European Scientific Retinal CongressesRead More
